SAINT-GENIS-POUILLY, FRANCE / ACCESSWIRE / November 28, 2016 / Advanced Accelerator Applications S.A. AAAP will host a conference call and live webcast to discuss the results of the Third Quarter 2016, to be held Monday, November 28, 2016 at 4:30 PM Eastern Time.
Live Event Information
To participate, connect approximately 5 to 10 minutes before the beginning of the event.
- Date, Time: November 28, 2016 at 4:30 PM ET
- Toll Free: 877-407-8133
- International: 201-689-8040
- Live Webcast: www.investorcalendar.com/IC/CEPage.asp?ID=175484 or www.adacap.com
Replay Information
The replay will be available beginning approximately 2 hours after the completion of the live event, ending at midnight Eastern on December 28, 2016.
- Toll Free: 877-481-4010
- International: 919-882-2331
- Replay ID#: 10163
- Webcast: www.investorcalendar.com or www.adacap.com
About Advanced Accelerator Applications
Advanced Accelerator Applications (AAA) is an innovative radiopharmaceutical company that develops, produces and commercializes Molecular Nuclear Medicine (MNM) products. AAA's lead therapeutic product candidate, Lutathera®, is a novel MNM compound that AAA is currently developing for the treatment of Neuro Endocrine Tumors, a significant unmet medical need. Founded in 2002, AAA has its headquarters in Saint-Genis-Pouilly, France. AAA currently has 22 production and R&D facilities able to manufacture both diagnostics and therapeutic MNM products, and has over 480 employees in 13 countries (France, Italy, UK, Germany, Switzerland, Spain, Poland, Portugal, the Netherlands, Belgium, Israel, the U.S., and Canada). AAA reported sales of €88.6 million in 2015 (+26.8% vs. 2014). AAA is listed on the Nasdaq Global Select Market under the ticker "AAAP". For more information, please visit: www.adacap.com.
SOURCE: Investor Calendar
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.